BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7679052)

  • 1. Multiple forms of intracellular and secreted mucins in a pancreatic cancer cell line.
    Ho JJ; Bi N; Siddiki B; Chung YS; Yuan M; Kim YS
    Cancer Res; 1993 Feb; 53(4):884-90. PubMed ID: 7679052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of new pancreatic cancer-reactive monoclonal antibodies directed against purified mucin.
    Ho JJ; Bi N; Yan PS; Yuan M; Norton KA; Kim YS
    Cancer Res; 1991 Jan; 51(1):372-80. PubMed ID: 1703039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of pancreatic cancer apomucin to mammary and intestinal apomucins.
    Byrd JC; Ho JJ; Lamport DT; Ho SB; Siddiki B; Huang J; Yan PS; Kim YS
    Cancer Res; 1991 Feb; 51(3):1026-33. PubMed ID: 1988113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anti-tumor activity and immune responses induced by human cancer-associated mucin core peptide].
    Ma Y; Yuan M; Fei L
    Zhonghua Zhong Liu Za Zhi; 1996 Nov; 18(6):419-21. PubMed ID: 9387291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucin synthesis and secretion in various human epithelial cancer cell lines that express the MUC-1 mucin gene.
    Dahiya R; Kwak KS; Byrd JC; Ho S; Yoon WH; Kim YS
    Cancer Res; 1993 Mar; 53(6):1437-43. PubMed ID: 8443822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucin-like antigens in a human pancreatic cancer cell line identified by murine monoclonal antibodies SPan-1 and YPan-1.
    Ho JJ; Chung YS; Fujimoto Y; Bi N; Ryan W; Yuan SZ; Byrd JC; Kim YS
    Cancer Res; 1988 Jul; 48(14):3924-31. PubMed ID: 2454732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of sialyl-Lewis(a) and sialyl-Lewis(x) with MUC-1 apomucin ina pancreatic cancer cell line.
    Ho JJ; Siddiki B; Kim YS
    Cancer Res; 1995 Aug; 55(16):3659-63. PubMed ID: 7627976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Access to peptide regions of a surface mucin (MUC1) is reduced by sialic acids.
    Ho JJ; Cheng S; Kim YS
    Biochem Biophys Res Commun; 1995 May; 210(3):866-73. PubMed ID: 7539263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of mucin antigens recognized by monoclonal antibodies raised against human colon cancer cells.
    Fukui S; Horie T; Numata Y; Kitagawa H; Nakada H; Kawasaki T; Funakoshi I; Yamashina I
    Cancer Res; 1991 Jan; 51(1):331-5. PubMed ID: 1988095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discrimination of MUC1 mucins from other sialyl-Le(a)-carrying glycoproteins produced by colon carcinoma cells using a novel monoclonal antibody.
    Baeckström D; Nilsson O; Price MR; Lindholm L; Hansson GC
    Cancer Res; 1993 Feb; 53(4):755-61. PubMed ID: 7679050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second generation anti-MUC1 peptide monoclonal antibodies.
    Xing PX; Prenzoska J; Quelch K; McKenzie IF
    Cancer Res; 1992 Apr; 52(8):2310-7. PubMed ID: 1373108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunohistochemical study and biodistribution of monoclonal antibody (Nd2) against human pancreatic cancer].
    Sawada T
    Nihon Geka Gakkai Zasshi; 1992 Jul; 93(7):739-47. PubMed ID: 1380634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of CA19-9, DU-PAN-2, and SPan-1 antigens on two types of normal salivary mucins.
    Ho JJ; Norton K; Chung YS; Kim YS
    Oncol Res; 1993; 5(9):347-56. PubMed ID: 7518709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humoral immunity against a tandem repeat epitope of human mucin MUC-1 in sera from breast, pancreatic, and colon cancer patients.
    Kotera Y; Fontenot JD; Pecher G; Metzgar RS; Finn OJ
    Cancer Res; 1994 Jun; 54(11):2856-60. PubMed ID: 7514493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human colon adenocarcinomas express a MUC1-associated novel carbohydrate epitope on core mucin glycans defined by a monoclonal antibody (A10) raised against murine Ehrlich tumor cells.
    Medina M; Vélez D; Asenjo JA; Egea G; Real FX; Gil J; Subiza JL
    Cancer Res; 1999 Mar; 59(5):1061-70. PubMed ID: 10070964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of alpha-N-acetylgalactosamine-O-serine/threonine (Tn) antigen-mediated cellular immune response for active immunotherapy in mice.
    Singhal A; Fohn M; Hakomori S
    Cancer Res; 1991 Mar; 51(5):1406-11. PubMed ID: 1997178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Tn human monoclonal antibodies generated following active immunization with partially desialylated ovine submaxillary mucin.
    O'Boyle KP; Wright K
    Hum Antibodies Hybridomas; 1994; 5(1-2):25-31. PubMed ID: 7532023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucin glycoproteins as tumor markers.
    Feller WF; Henslee JG; Kinders RJ; Manderino GL; Tomita JT; Rittenhouse HG
    Immunol Ser; 1990; 53():631-72. PubMed ID: 2100576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the major sialyl-Lex-positive mucins present in colon, colon carcinoma, and sera of patients with colorectal cancer.
    Hanski C; Hanski ML; Zimmer T; Ogorek D; Devine P; Riecken EO
    Cancer Res; 1995 Feb; 55(4):928-33. PubMed ID: 7850810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The C-type lectin MGL expressed by dendritic cells detects glycan changes on MUC1 in colon carcinoma.
    Saeland E; van Vliet SJ; Bäckström M; van den Berg VC; Geijtenbeek TB; Meijer GA; van Kooyk Y
    Cancer Immunol Immunother; 2007 Aug; 56(8):1225-36. PubMed ID: 17195076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.